Bayer AG (BAYN.XE) said Monday that it has made further concessions to European regulators as part of its $63.5 billion bid to acquire Monsanto Co MON, +2.22% .

The German pharma company said it submitted "very significant" remedies to the European Commission and that it is confident the offered concessions fully address the regulator's concerns.